Vyne Therapeutics Inc Revenue per Employee (VYNE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vyne Therapeutics Inc   (NASDAQ: VYNE)
 

Vyne Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Vyne Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 43,000, below the company average number of $611,423.
Within the Healthcare sector Employees of 502 other companies have achieved higher revenue per employee. While Vyne Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 3059 to 3493. Vyne Therapeutics Inc has 10 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VYNE Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Revenue Change -51.98 % 2.38 % 47.11 % -65.15 % 106.12 %
Sales per Employee (TTM) $ 43,000 53,500 53,300 47,600 60,500
VYNE's Total Ranking # 3493 # 3059 # 2321 # 2860 #
Seq. Revenue Change 12.79 % -51.69 % 157.97 % -65.84 % 140.48 %

VYNE Company Profile >> Back to VYNE Efficiency Comparisons >> Compare VYNE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 179
Healthcare Sector # 503
Overall Market # 3493

Revenue per Employee Statistics
High Average Low
$ 2,336,200 $ 611,423 $ 35,400
(Mar 31 2021)   (Sep 30 2023)



Financial Statements
Vyne Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit VYNE's Income Statement
Vyne Therapeutics Inc 's Revenues TTM $ 0 Millions Visit VYNE's aggregate revenue growth
What are VYNE's Sales? Visit VYNE's Sales by Segment




Other Ratios
Vyne Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VYNE's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VYNE's Competitors
Revenue per Employee for VYNE's Suppliers
Revenue per Employee for VYNE's Customers

You may also want to know
VYNE's Sales Growth Rates VYNE's Pe Price to earnings ratio VYNE's Receivables Turnover Ratio VYNE's Stock Quote
VYNE's Net Income Growth Rates VYNE's Ps Price to Sales ratio VYNE's Sales per Employee VYNE's Asset Turnover Ratio
VYNE's Net Margin VYNE's Pb Price to Book ratio VYNE's Financial Strength Ratios VYNE's Dividend Payout Ratio
Date modified: 2026-09-02T20:18:22+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Lakeland Industries Inc   73,446.54 $ 190.961  Million 2,600 
Igc Pharma Inc   73,400.00 $ 1.101  Million 15 
Newamsterdam Pharma Company N v   71,210.00 $ 7.121  Million 100 
Crinetics Pharmaceuticals Inc   70,969.70 $ 42.156  Million 594 
Atrium Therapeutics Inc   70,399.22 $ 35.974  Million 511 
Onemednet Corporation  69,130.43 $ 1.590  Million 23 
Sharps Technology Inc   67,593.76 $ 1.960  Million 29 
Crispr Therapeutics Ag  66,626.87 $ 13.392  Million 201 
Ispecimen inc   66,614.57 $ 0.466  Million 7 
Lucid Diagnostics Inc   66,402.44 $ 5.445  Million 82 
Cannapharmarx Inc   65,342.92 $ 1.699  Million 26 
Agape Atp Corporation  64,026.78 $ 1.152  Million 18 
Vistagen Therapeutics Inc   61,000.00 $ 2.501  Million 41 
Blue Water Vaccines Inc  58,711.64 $ 0.646  Million 11 
Dar Bioscience Inc   56,031.96 $ 1.345  Million 24 
Petvivo Holdings Inc   53,712.00 $ 1.182  Million 22 
Vsee Health Inc   51,479.38 $ 10.759  Million 209 
Tscan Therapeutics Inc   50,077.46 $ 7.111  Million 142 
Cg Oncology Inc   43,859.15 $ 6.228  Million 142 
Biocorrx Inc   43,701.83 $ 0.787  Million 18 
Vyne Therapeutics Inc   43,000.00 $ 0.430  Million 10 
Femasys Inc   42,581.67 $ 2.299  Million 54 
Upstream Bio Inc   42,106.67 $ 3.158  Million 75 
Sintx Technologies Inc   41,562.50 $ 1.330  Million 32 
Fate Therapeutics Inc   40,316.77 $ 6.491  Million 161 
Ocugen Inc   39,482.76 $ 4.580  Million 116 
Alumis inc   33,026.79 $ 7.398  Million 224 
Volitionrx Limited  32,773.92 $ 2.458  Million 75 
Longeveron Inc   31,236.84 $ 1.187  Million 38 
Entrada Therapeutics Inc   30,828.95 $ 4.686  Million 152 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.